Cas No.: | 139667-74-6 |
Chemical Name: | CGP 52432 |
Synonyms: | CGP 52432;3-[(3,4-dichlorophenyl)methylamino]propyl-(diethoxymethyl)phosphinic acid;[3-[[(3,4-Dichlorophenyl)methyl]amino]propyl](diethoxymethyl)-phosphinic acid;Tocris-1246;CGP52432 |
SMILES: | O=P(C(OCC)OCC)(CCCNCC1=CC=C(Cl)C(Cl)=C1)O |
Formula: | C15H24NO4PCl2 |
M.Wt: | 384.23516 |
Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
Description: | CGP52432 is a GABAB receptor antagonist, with an IC50 of 85 nM. |
In Vivo: | CGP52432 (10, 30 mg/kg) shows no effect on the total arm entries and total head dips of mice on the elevated-plus maze[2]. CGP52432 (100 nmol/kg, i.v., or 1 nmol/kg, i.c.v.) abolishes the suppressive effects of GABA ( 50 μmol/kg, i.v.) on enhanced renal sympathetic nerve activity (RSNA) during ischaemia, causeing elimination of the renoprotective effects of GABA in rats[3]. |
In Vitro: | CGP52432 is a GABAB receptor antagonist, with an IC50 of 85 nM, 35- and 100-fold lower than at the receptors regulating somatostatin and glutamate overflow, respectively[1]. |